ESG Report

Overview

The report describes Mabion's 2024 transformation into a biologics CDMO, reporting PLN 69 million in year-end revenue and achievement of its planned 2023-2024 strategic goals. It highlights the first year of ESG Strategy implementation, with 89% of 2024 tasks completed and 30 social and environmental actions implemented. The company also reports Scope 1, 2 and 3 carbon-footprint calculations across its two locations, including Scope 3 category detail.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services